Race, institutional factors play an important role in pharmacogenomic trial participation

28 julio 2015

The participation rate of patients in pharmacogenomic trials has been the focus of recent study. The research has concluded that there are a number of factors at the patient, physician, institution and community level that serve as incentives or hindrances for clinical trial participation, including beliefs and attitudes, awareness, opportunities and resources.img src=»http://feeds.feedburner.com/~r/sciencedaily/~4/ffdgEH3FJlM» height=»1″ width=»1″ alt=»»/